This site is intended for Healthcare Professionals only.

EU disease prevention agency sees risk of Covid deaths rising as Omicron subvariants spread

Date:

Share post:

Two new subvariants of Omicron — BA.4 and BA.5 — are spreading much faster than other corovanirus variants in Europe, which could lead to more hospitalizations and deaths as they become dominant, the EU’s disease prevention agency said on Monday (June 13).

Most EU countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen – such as Portugal, where BA.5 accounted for 87 per cent of cases by May 30 — there have been surges in overall cases, according to the European Centre for Disease Prevention and Control (ECDC).

The two sublineages were added to the World Health Organization’s monitoring list in March and have also been designated as variants of concern by the ECDC.

Variants BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron. But an increase in case numbers from higher transmission rates risks leading to an increase in hospitalizations and deaths, the agency said.

“The growth advantage reported for BA.4 and BA.5 suggest that these variants will become dominant,” ECDC said in a statement on its website.

Meanwhile, its US counterpart said last week BA.4 and BA.5 were estimated to make up nearly 5 per cent and 8 per cent, respectively, of coronavirus cases as of June 4.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

RPS proposes transition to Royal College, seeks feedback from pharmacy community

The proposed changes will need approval from RPS members through a vote, which is anticipated in early 2025 The...

COVID-19 Inquiry: RPS calls for greater recognition and support for pharmacists

Despite their crucial role during the pandemic, community pharmacy was often an afterthought in government planning, guidance and...

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

CPTPP membership could attract more suppliers to the UK market, thereby reduce drug shortage risks and lower prices...

Community pharmacy ‘overlooked’ during pandemic, NPA tells Covid-19 Inquiry

The NPA asked the Inquiry to consider the resilience of community pharmacy in responding to a future pandemic At...